Effect of stainless steel corrosion products on in vitro biomineralization

Journal of Biomaterials Applications

Volumn 14, Issue 2, 1999, Pages 113-168

  Fernandes, Maria Helena ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; CORROSIVE EFFECTS; STAINLESS STEEL; STEEL CORROSION; TISSUE CULTURE;

BIOMINERALIZATION; STAINLESS STEEL AISI 316L;

BIOMATERIALS;

ALKALINE PHOSPHATASE; BIOMATERIAL; STAINLESS STEEL;

ANIMAL; ARTICLE; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CORROSION; CYTOLOGY; ELECTRON MICROSCOPY; ENZYMOLOGY; HUMAN; METABOLISM; OSTEOBLAST; RAT; ULTRASTRUCTURE; WISTAR RAT;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CORROSION; HUMANS; MICROSCOPY, ELECTRON; OSTEOBLASTS; RATS; RATS, WISTAR; STAINLESS STEEL;

EID: 0033237820     PISSN: 08853282     EISSN: None     Source Type: Journal    
DOI: 10.1177/088532829901400202     Document Type: Article

References (110)

1. Williams, D., Cahn, R.W., and Bever, M.B., Concise Encyclopedia of Medical & Dental Materials. Pergamon Press (1990).
2. Park, J., "Metallic biomaterials," in The Biomedical Engineering Handbook. Bronzine, J: CRC Press, pp. 537-551 (1995).
3. Barbosa, M.A., "Surface layers and the reactivity of metallic implants," in Biomaterials Hard Tissue Repair and Replacement. Muster, D: Elsevier Science Publishers, pp. 227-283 (1992).
4. Brown, S.A., and Simpson, J.P., "Crevice and fretting corrosion of stainless steel plates and screws," J. Biomed. Mater. Res., 15, 867-878 (1981).
5. Pohler, O.E.M., "Degradation of metallic orthopedic implants," in Biomaterials in Reconstructive Surgery. Rubin LP: C.V. Mosby, pp. 158-228 (1983).
6. Pourbaix, M., "Electrochemical corrosion of metallic biomaterials," Biomaterials, 5, 122-134 (1984).
7. Fraker, A.C., Corrosion and Degradation of Implant Materials. Fraker, AC and Griffin, CD: American Society for Testing Materials (1985).
8. Van Orden, A., "Corrosive response of the interface tissue to 316L stainless steel, titanium-based alloy and cobalt-based alloys," in The Dental Implant. McKinney, R and Lemons, JE: PSG, pp. 1-25 (1985).
9. Fontana, M.G., Corrosion Engineering. McGraw-Hill Book Co. (1986).
10. Gilbert, J., Buckley C., and Jacobs, J., "In vitro corrosion of modular hip prosthesis compounds in mixed and similar metal combinations. The effect of crevice, stress, motion and alloy coupling," J. Biomed. Mater. Res., 27, 1533-1544 (1993).
11. Merritt, K., and Brown, S.A., Proceedings of the symposium on Compatibility of Biomedical Implants. Kovacs P, and Istephanous NS: The Electrochemical Society Inc., vol. 94 (15) pp. 14-20 (1994).
12. Xulin, S., Atsuo, I., and Hoshino A., "Fretting corrosion resistance and fretting corrosion product cytocompatibility of ferric stainless steel," J. Biomed. Mater. Res., 34, 9-14 (1997).
13. Skinner, H., Weinstein, A., Clemow, A., McPhillips, M., Klawitter, J., and French, G., "Corrosion materials and local tissue reaction associated with osteosynthesis devices," in Implant Retrieval: Material and Biological Analysis. NBS Special Publication 601, pp. 423-448 (1981).
14. Williams, D., Black, J., and Doherly, P., "Biomaterial-tissue interfaces," Proceedings of the 9th European Conference on Biomaterial. Advances in Biomaterials. Elsevier Science Publishers, 10, 525-533 (1992).
15. Galante, J., Lemons, J., Spector, M., Wilson, P., and Wright, T., "The biologic effects of implant materials," J. Orthop. Res., 9, 760-775 (1991).
16. Dobbs, H.S., and Minski, M.J., "Metal ions release after total hip replacement," Biomaterials, 1, 193-198 (1980).
17. Brown, S.A., Farnsworth, L.J., Merritt, K., and Crowe, T., "In vitro and in vivo metal ion release," J. Biomed. Mater. Res., 22, 321-338 (1988).
18. Williams, D.F., "Biocompatibility: performance in the surgical reconstruction of man," Interdiscip. Sci. Rev., 15, 20-33 (1990).
19. Pilliar, R.M., "Porous-surface metallic implants for orthopedic applications," J. Biomed. Mater. Res., 21, 1-33 (1987).
20. Bobyn, J.D., Tanzer, M., Drygier, J.J., Du Joune, A.R., and Brooks, C.E., "Concerns with modularity in total hip arthroplastry," Clin. Orthop., 298, 27-36 (1994).
21. Black, J., Biological Performance of Materials. Dekker, M. (1992).
22. Di Carlo, E., and Bullough, P., "The biological responses to orthopedic implants and their wear debris," Clin. Mat., 9, 235-269 (1992).
23. Dorr, L.D., Blocbaum, R., Emmanualy, J., and Meldrum, R., "Histologic, biochemical and ion analysis of tissue and fluids retrieved during total hip arthroplasty," Clin. Orthop., 261, 82-95 (1990).
24. Hennig, F.F., Raithel, H.J., Schaller, K.H, and Dohler J.R., "Nickel-chromium and cobalt concentrations in human tissue and body fluids of hip prosthesis patients," J. Trace Elem. Electrolytes Health Dis., 6, 239-243 (1992).
25. Bartolozzi, A., and Black, J., "Chromium concentrations in serum, blood clot and urine from patients following total hip arthroplasty," Biomaterials, 6, 2-8 (1985).
26. Linden, J.V., Hopler, S.M., Gossling, H.R., and Sunderman Jr, F.W., "Blood nickel concentrations in patients with stainless steel hip protheses," Ann. Clin. Lab. Sci, 15, 459-464 (1985).
27. Black, K., Maitin, E.C., Gelman, H., and Morris, D.M., "Serum concentrations of chromium, cobalt, and nickel after total hip replacement; a six month study," Biomaterials, 4, 160-164 (1983).
28. Pereira, M.L., Abreu, A.M., Sousa, J.P., and Carvalho, G.S., "Chromium accumulation and ultrastructural changes in the mouse liver caused by stainless steel corrosion products," J. Mater. Sci. Mater. Med., 6, 523-527 (1995).
29. Smith, G.K., and Black, J., "Estimation of in vivo type 316L stainless steel corrosion rate from blood transport and organ accumulation data," in Corrosion and Degradation of Implant Materials: Second Symposium, ASTM STP 859. Fraker, AC and Griffin, CD: American Society for Testing Materials, pp. 223-247 (1985).
30. Lugowski, S.J., Smith, D.C., McHugh, A.D., and Van Loon, J.C., "Release of metal ions from dental implants materials in vivo: determination of Al, Co, Cr, Mo, Ni, V and Ti in organ tissue," J. Biomed. Mater. Res., 25, 1443-1458 (1991).
31. Deutman, R., Rulder, T.J., Brian, R., and Nater, J.P., "Metal sensitivity before and after total hip arthroplasty," J. Bone Joint. Surg., 59A, 862-865 (1977).
32. Smith, G.K., and Black, J., "Models for systemic effects of corrosion products," in Retrieval and Analysis of Orthopedics Implants. Weinstein, A, Gibbons, D, Brown, SA and Ruff, AW: NBS Special Publication 472, U.S. Government Printing Office, Washington D.C., pp. 23-28 (1977).
33. Merritt, K., and Brown, S.A., "Biological effects of corrosion products from metals," in Corrosion and Degradation of Implant Materials: Second Symposium, ASTM STP 859. Fraker, AC and Griffin, CD: American Society for Testing Materials, pp. 195-207 (1985).
34. Tracana, R.B., Pereira, M.L., Abreu, A.M., Sousa, J.P, and Carvalho, G.S., "Stainless steel corrosion products cause alterations on mouse spleen cellular populations," J. Mater. Sci. Mater. Med., 6, 56-61 (1995).
35. Bravo, I., Sousa, S.R., Carvalho, G.S., and Barbosa, M., "Metals electrochemically dissolved in human serum inhibit T-lymphocyte function," in Advances in Biomaterials. Doherty, PJ: Elsevier, pp. 7-11 (1992).
36. Carvalho, G.S., Castanheira, M., Diogo, L, Abreu, A.M., Sousa, J.E, Loon, J.A., and Blitterswijk, C.A., "Inhibition and stimulation of enzymatic activities of human fibroblasts by corrosion products and metal salts," J. Mater. Sci. Mater. Med., 7, 77-83 (1995).
37. Evans, E.M., Freeman, M.A.R., Miller, A.J., and Vernon-Roberts, B., "Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement," J. Bone Joint Surg., 56B, 626-642 (1974).
38. Ferguson, G.M., and Evans, C.H., "The possible role of implant materials in promoting the aseptic loosening of prosthetic joints," in Interaction of Cells with Natural and Foreign Surfaces. Crawford, N and Taylor, DEM: Plenum Press, pp. 279-286 (1986).
39. Pohler, O., "Failure of metallic orthopedic implants," in Metals Handbook Vol. II. ASTM International Metals Park: pp. 670-694 (1987).
40. Puleo, D.A., and Huh, W.W., "Acute toxicity of metal ions in cultures of osteogenic cells derived from bone marrow stromal cells," J. Appl. Biomater., 6, 109-116 (1995).
41. Thompson, G.J., and Puleo, D.A., "Effects of sublethal metal ion concentrations on osteogenic cells derived from bone marrow stromal cells," J. Appl. Biomater., 6, 249-258 (1995).
42. Nichols, K., and Puleo, D., "Effect of metal ions on the formation and function of osteoclastic cells in vitro," J. Biomed. Mater. Res., 35, 265-271 (1997).
43. Tomás, H., Carvalho, G.S., Fernandes, M.H., Freire, A.P., and Abrantes, L.M., "Effects of Co-Cr corrosion products and corresponding separate metal ions on human osteoblast-like cell cultures," J. Mater. Sci. Mater. Med., 7, 291-296 (1996).
44. Tomás, H., Carvalho, G.S., Fernandes, M.H., Freire, A.P., and Abrantes, L.M., "The use of rat, rabbit or human bone marrow derived cells for cytocompatibility evaluation of metallic elements," J. Mater. Sci. Mater. Med., 8, 233-238 (1997).
45. Sun, Z.L., Wataha, J.C., and Hanks, C.T., "Effects of metal ions on osteoblast-like cell metabolism and differentiation," J. Biomat. Mater. Res., 34, 29-37 (1997).
46. Yamamoto, A., Honma, R., and Sumita, M., "Cytotoxicity evaluation of 43 metal salts using murine fibroblasts and osteoblastic cells," J. Biomed. Mater. Res., 39, 331-340 (1998).
47. Morais, S., Sousa, J.P., Fernandes, M.H., and Carvalho, G.S., "In vitro biomineralization by osteoblast-like cells. I. Retardation of tissue mineralization by metal salts," Biomaterials, 19, 13-21 (1998).
48. Morais, S., Sousa, J.P., Fernandes, M.H., Carvalho, G.S., de Bruijn, J.D., and van Blitterswijk, C.A., "Effects of AISI 316L corrosion products in in vitro bone formation," Biomaterials, 19, 999-1007 (1998).
49. Morais, S., Sousa, J.P., Fernandes, M.H., Carvalho, G.S., de Bruijn, J.D., and van Blitterswijk, C.A., "Decreased consumption of Ca and P during in vitro biomineralization and biologically induced deposition of Ni and Cr in presence of stainless steel corrosion products," J. Biomed. Mater. Res., 42, 199-212 (1998).
50. Morais, S., Dias, N., Fernandes, M.H., and Carvalho, G.S., " In vitro osteoblastic differentiation of human bone marrow cells in the presence of metal ions," J. Biomed. Mater. Res., 44, 176-190 (1999).
51. Costa, M.A., and Fernandes, M.H., "Proliferation/differentiation of osteoblastic human alveolar bone cell cultures in the presence of stainless steel corrosion products," J. Mater. Sci. Mater. Med., 10, to appear.
52. Aubin, J.E., Turksen, K., and Heersch, J.N.M., "Osteoblastic cell lineage," in Cellular and Molecular Biology of Bone. Noda, M: Academic Press Inc., pp. 1-45 (1993).
53. Martin, T.J., Findlay, D.M., Heath, J.K., and Ng, K.W., "Osteoblasts: differentiation and function," in Handbook of Experimental Pharmacology. Mundy, JR, and Martin, TJ: Springer-Verlag, pp. 149-183 (1993).
54. Kirkpatrick, C. J., "A critical view of current and proposed methodologies for biocompatibility testing: Cytotoxicity in vitro," Regulatory Affairs, 4, 13-22 (1992).
55. Pizzoferrato, A., Ciapetti, G., and Stea, S., "Cell culture methods for testing biocompatibility," Clin. Mater., 15, 173-190 (1994).
56. Bizios, R., "Mini review: osteoblasts: an in vitro model of bone-implant interactions," Biotechnol. Bioeng., 43, 582-585 (1994).
57. KirkPatrick, C.J., Wagner, M., Kohler, H., Bittinger, F., Otto, M., and Klein, C.L., "The cell and molecular biological approach to biomaterial research: a perspective," J. Mater. Sci: Mater. Med., 8, 131-141 (1997).
58. Fernandes, M.H., Costa, M.A., and Carvalho, G.S., "In vitro osteogenesis by human alveolar bone cells in the presence of dexamethasone," Pharmacol. Res., 31 (suppl), 8 (1995).
59. Fernandes, M.H., Costa, M.A., and Carvalho, G.S, "Mineralization in serially passaged human alveolar bone cells," J. Mater. Sci: Mater. Med., 8, 61-65 (1997).
60. Fernandes, M.H., "Long-term behavior of osteoblast-like human alveolar bone cell cultures," Bull. Group. Int. Rech. Sci. Stomatol. Odontol., 40, 65-75 (1998).
61. Coelho, M.J., Trigo Cabral, A., Carvalho, G.S., and Fernandes, M.H., "Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in α-MEM and in DMEM," submitted to Biomaterials.
62. Coelho, M.J., and Fernandes, M.H., "Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, β-glycerophosphate and dexamethasone in the osteoblastic differentiation," submitted to Biomaterials.
63. Ninomiya, J.T., Tracy, R.P., and Calore, J.D., " Heterogeneity of human bone," J. Bone Miner. Res., 5, 933-938 (1990).
64. Kasperk, C., Schneider, U., and Sommer, U., "Human bone cell phenotypes differ depending on their skeletal site of origin," J. Clin. Endocrinol. Metab., 80, 2511-2517 (1995).
65. Denkouski, P., Tertinegg, I., and Heersche, J.N.M., "Heterogeneity between osteoblastic populations isolated from different adult rat skeletal sites," Bone Miner., 25, S8 (1994).
66. Marie, P.J., and de Vernejoul, M.C., "Proliferation of bone surface derived osteoblast cells and control of bone formation," Bone, 14, 463-468 (1993).
67. Maniatopoulos, C., Sodek, J., and Melcher, A., "Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats," Cell Tissue Res., 254, 317-330 (1988).
68. Aronow, M.A., Gerstenfeld, L.C., and Owen, T.A., "Factors that promote progressive development of the osteoblastic phenotype in cultured fetal rat calvaria cells," J. Cell Phys., 143, 213-221 (1990).
69. Stein, G.S., and Lian, J.B., "Molecular mechanisms mediating developmental and hormone-regulated expression of genes in osteoblasts: an integrated relationship of cell growth and differentiation," in Cellular and Molecular Biology of Bone. Noda M.: Academic Press Inc., pp. 47-95 (1993).
70. Gundle, R., Joyner, C.J., and Triffit, J.T., "Human bone tissue formation in diffusion chamber culture in vivo by bone derived cells and marrow stromal fibroblastic cells," Bone, 16, 597-601 (1995).
71. Stein, G.S., and Lian, J.B., "Molecular mechanisms mediated proliferation-differentiation interrelationships during progressive development of the osteoblastic phenotype: Update 1995," End. Rev., 4, 290-297 (1995).
72. Cheng, S.L., Yang, J.W., and Riffins, T., "Differentiation of human bone marrow osteogenic stromal cells in vitro. Induction of the osteoblastic phenotype by dexamethasone," Endocrinology, 134, 277-286 (1994).
73. Merritt, K., Wortman, R.S., Millard, M., and Brown, S.A., "XPS analysis of 316 LVM corroded in serum and in saline," Biomater. Med. Devices Artif. Org., 11, 115-127 (1983).
74. McGee-Russel, S.M., "Histochemical methods for calcium," J. Histochem. Cytochem., 6, 22-42 (1958).
75. Berridge, V., and Tan, A.S., "Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction," Arch. Biochem. Biophys., 303, 474-482 (1993).
76. Morais, S., Carvalho, G.S., and Sousa, J.P., "Potentiometric determination of total and ionized calcium in osteoblast-like cell culture medium," Electroanalysis, 8, 1174-1178 (1996).
77. Morais, S., Carvalho, G.S., and Sousa, J.P., "Iron determination in osteoblast-like cell culture medium by adsorptive cathodic stripping voltammetry with a mercury microelectrode," Electroanalysis, 9, 791-795 (1997).
78. Morais, S., Carvalho, G.S., and Sousa, J.P., "Determination of nickel in osteoblast-like cell culture medium by adsorptive cathodic stripping voltammetry with mercury microelectrodes," Electroanalysis, 9, 422-426 (1997).
79. Morais, S., Carvalho, G.S., and Sousa, J.P., "Chromium determination in osteoblast-like cell culture medium by catalytic cathodic stripping voltammetry with a mercury microelectrode," J. Trace Elements Med. Biol., 2, 101-108 (1998).
80. Owen, M., "Marrow stromal stem cells," J. Cell Sci. Suppl., 10: 63-76 (1988).
81. Manolagas, S.C., "Bone marrow, clastic, and blastic cell system: quo vadis?," Calcif. Tissue Int., 56, S52-S53 (1995).
82. Friedenstein, A.J., "Marrow stromal fibroblasts," Calcif. Tissue Int., 56, S17 (1995).
83. Anderson, H.C., and Morris, B.C., "Mineralization," in Handbook of Experimental Pharmacology. Mundy, JR, and Martin, TJ: Springer-Verlag, pp. 267-298 (1993).
84. Gundle, R., and Beresford, J.N., "The isolation and culture of cells from explants of human trabecular bone," Calcif. Tissue Int., 56, S8-S10 (1995).
85. Robey, P.G., "Collagenase-treated trabecular bone fragments: a reproducible source of cells in the osteoblastic lineage," Calcif. Tissue Int., 56, S11-S12 (1995).
86. Hayflick L., "The limited in vitro lifetime of human diploid cell strains," Exp. Cell Res., 37, 614-636 (1965).
87. Freshney, R.I., "The culture environment: substrate, gas phase, medium and temperature," in Culture of Animal Cells: a Manual of Basic Technique. Freshney, RI: Wiley-Liss, pp. 71-101 (1994).
88. Chavassieux, P.M., Chenu, C., and Valentin-Opran, A., "Influence of experimental conditions on osteoblast activity in human primary bone cell cultures," J. Bone Miner. Res., 5, 337-343 (1990).
89. Rattner, A., Sabido, O., Massoubre, C., Rascle, F., and Frey, J., "Characterization of human osteoblastic cells: influence of the culture conditions," In vitro Cell. Dev. Biol., 33, 757-762 (1997).
90. Bellows, C.G., Aubin, J.E., and Heersche, J.N.M., "Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate," Bone and Min., 14, 27-40 (1991).
91. Bellows, C.G., Heersch, J.N.M., and Aubin, J.E., "Inorganic phosphate added exogenously or released from β-glycerophosphate initiates mineralization of osteoid nodules in vitro," Bone and Mineral, 17, 15-29 (1992).
92. Chung, C.H., Golub, E.E., Forbes, E., Tokuoka, T., and Shapiro, I.M., "Mechanism of action of ß-glycerophosphate on bone cell mineralization," Calcif. Tissue Int., 51, 305-311 (1992).
93. Franceschi, R.T., "The role of ascorbic acid in mesenchymal differentiation," Nutr. Rev., 50, 60-65 (1992).
94. Owen, T.A., Aronow, M., and Shalhoub, V., "Progressive development of the rat osteoblastic phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation during formation of bone extracellular matrix," J. Cell Phys., 143, 420-430 (1990).
95. Lynch, M.P., Stein, J.L., Stein, G.S., and Lian, J.B., "The influence of type I collagen on the development and maintenance of the osteoblastic phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion and extracellular matrix mineralization," Exp. Cell Res., 216, 35-45 (1995).
96. Gwynn, I.A.P., "Cell biology at interfaces," J. Mat. Sci: Mat. Med., 5, 357-360 (1994).
97. De Bruijn, J.D., Kein, C.P.A.T., de Groot, K., and van Blitterswijk, C.A., "The ultrastructure of the bone hydroxyapatite interface in vitro," J. Biomed. Mater. Res., 26, 1365-1382 (1992).
98. Davies, J.E., Chernecky, R., Lowenberg, B., and Shiga, A., "Deposition and resorption of calcified matrix in vitro by rat marrow cells," Cells Mater., 1, 3-15 (1991).
99. Rae, T., "The toxicity of metals used in orthopaedic prostheses," J. Bone Joint Surg., 63B, 435-440 (1981).
100. Lucas, L.C., Bearden, L.J., and Lemons, J.E., "Ultrastructural examination of in vitro and in vivo cells exposed to elements from type 316L stainless steel," in Corrosion and Degradation of Implant Materials: Second Symposium. ASTM STP 859. Fraker, AC, and Griffin, CD: American Society for Testing and Materials, pp. 208-222 (1985).
101. 2+ from its complexes with proteins and other ligands by mouse dermal fibroblasts in vitro," Br. J. Cancer, 26, 292-298 (1972).
102. Katz, S.A., and Salem, H., "The toxicology of chromium with respect to its speciation: a review," J. Appl. Toxicol., 13, 217-224 (1993).
103. Bianchi, V., Toso, R.D., and Debetto, P., "Mechanisms of chromium toxicity in mammalian cell cultures," Toxicology, 17, 219-224 (1980).
104. Levis, A.G., and Majone, F., "Cytotoxic and clastogenic effects of soluble chromium compounds on mammalian cell cultures," Br. J. Cancer, 40, 523-533 (1979).
105. Vincent, J., "Chromium: biological relevance," in Encyclopedia of Inorganic Chemistry, vol. II. King, R: John Wiley & Sons, pp. 661-665 (1994).
106. O'Flaherty, E., "A pharmacokinetic model for chromium," Toxicol. Lett., 68, 145-158 (1993).
107. Baron, R., "Anatomy and ultrastrucuture of bone," in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 2nd edition. Favus, MJ: Raven Press, pp. 3-37 (1993).
108. Merritt, K., Brown, S.A., and Sharkey, N.A., "The binding of metal salts and corrosion products to cells and proteins in vitro," J. Biomed. Mater. Res., 18, 1005-1015 (1984).
109. Wataha, J.C., Hanks, C.T. and Craig, R.C., "Uptake of metal cations by fibroblasts in vitro," J. Biomed. Mater. Res., 27, 227-232 (1993).
110. Woodman, J.L., Black, J., and Jiminez, S.A., "Isolation of serum proteins organometallic corrosion products from 316L stainless steel and HS-21 in vitro," J. Biomed. Mater. Res., 18, 99-114 (1984).